Daniel G. Baker SEC EDGAR Filings (CIK 0002046802)

SEC EDGAR filings, ownership reports, and insider transactions for Daniel G. Baker.

Business address
C/O Cue Biopharma, Inc., 40 Guest Street, Boston, MA, 02135
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Daniel G. Baker has filed 9 SEC EDGAR filings since 29 Nov 2024

Latest Filings

Recent SEC filings for Daniel G. Baker including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 25 Nov 2025 29 Sep 2025 001-38327
4 Open 4 document View SEC filing for 4 4 02 Sep 2025 28 Aug 2025 001-39593
3 Open 3 document View SEC filing for 3 3 02 Sep 2025 25 Aug 2025 001-39593
4 Open 4 document View SEC filing for 4 26 Jun 2025 24 Jun 2025 001-42179
4 Open 4 document View SEC filing for 4 4 25 Mar 2025 21 Mar 2025 001-38327
4 Open 4 document View SEC filing for 4 29 Jan 2025 28 Jan 2025 001-42179
3 Open 3 document View SEC filing for 3 29 Jan 2025 28 Jan 2025 001-42179
4 Open 4 document View SEC filing for 4 4 29 Nov 2024 25 Nov 2024 001-38327
3 Open 3 document View SEC filing for 3 3 29 Nov 2024 25 Nov 2024 001-38327

About this filer

Daniel G. Baker files with the SEC under CIK 0002046802. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages